The Compelling Case for Better Screening and Secondary Prevention in Europe
We would like to share an insight report from our friends "Health First Europe" who tried to explore compelling cases for better screening and secondary prevention in Europe. In this report, you can learn lessons from five representative diseases.
The purpose of this paper is to highlight the value of screening and secondary prevention in general for improving patient safety, the quality of care in healthcare settings and quality of life across Europe. Regular exams and screening tests can detect disease in its earliest stages, dramatically increasing the likelihood of preventing the worst impacts of diseases and restoring patients’ health and well-being to their previous state. Increased screening and secondary prevention can also substantially reduce the cost of public health services over the long term.
Europe has many national success stories that could be better shared and implemented across borders. This Insight Report showcases concrete examples and solutions for implementing national screening programmes which have been successful in improving outcomes for patients and society in five representative disease areas: breast cancer, type 2 diabetes, healthcare-associated infections, heart failure, and new-born and severe combined immune deficiency (SCID).
You might also enjoy
Resolution: Framework for Action on the Health and Care Workforce in the WHO European Region 2023–2030
At the 73rd Regional Committee for Europe held in Astana, 24–26 October 2023, the 53 countries in the Region unanimously adopted a Resolution in support of a new Framework for Action on the Health and Care Workforce.
Policy on Violence Against Doctors
Adopted at the General Assembly in Murcia, Spain, on 27 September 2023.
EJD Statement of support to the Polish Medical Chamber on upholding medical education quality training standards amidst the surge of new medical schools
Adopted at the Autumn Meeting - General Assembly 2023 in Murcia, Spain.